Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 150

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 150
---
 associated with sequencing and increases the coverage quality and data output. |

| ● | Preimplantation Genetic Diagnosis (“PGD”): Similar to PGS, PGD is also used in parallel with an IVF treatment cycle. But PGD is a process more enhanced than PGS since it scans for individual genes. PGD is the practice of evaluating embryos for specific genetic abnormalities, such as sickle cell disease or cystic fibrosis, where carrier status has been documented in each of the parents. By using this technique, physicians are able to check the genes or chromosomes for a specific genetic condition. PGD can decrease the risk of miscarriage and this technology can help women better achieve a healthy pregnancy. Individuals who suspect or know they carry genes for serious medical conditions may opt to screen for healthy embryos ahead of time. |

Well Established Brand with Reliable Reputation

The founders of NewGenIvf
entered the fertility market as agents in 2011 by introducing patients in need to a Thailand clinic for fertility treatments. The founders
of NewGenIvf started to operate their own clinic in Thailand in 2014 and subsequently added clinics in Cambodia and Kyrgyzstan. Since
then, NewGenIvf has attracted clients from countries throughout Asia-Pacific, including Mainland China, Hong Kong, India, Thailand,
Australia and Taiwan.

NewGenIvf benefits from the
favourable geographic locations of its clinics, especially its clinic in Thailand. Located in central Bangkok and situated in one of the
biggest shopping malls of the city, the clinic is located in close proximity to various transportation facilities and popular tourist
attractions, such as the Erawan Shrine. In this regard, NewGenIvf believes that its business has benefited from, and will continue to
benefit from, the convenience of its locations.

<div align='center'>88</div>

NewGenIvf has developed a
relatively replicable and scalable operating model that supports high productivity at its assisted reproductive medical facilities in
Asia. Under this model, NewGenIvf’s medical facilities have established standardized operating procedures to select the treatment
process according to each patient’s profile. NewGenIvf’s medical and operational personnel are organized into specialized
teams according to the different stages of the treatment process and different patient profiles. When patients are initially admitted
or would like to seek additional medical services later on, they are assigned to one of the optimal medical teams, which NewGenIvf believes
is better suited after taking into account the patient’s diagnosis and preferences